INTRODUCTION
MazF is a toxin encoded by the Escherichia coli chromosome and is assumed to play an important role in stress adaptation [1] [2] [3] [4] . It functions as an mRNA interferase, which specifically cleaves cellular mRNAs at ACA nucleotide sequences 5, 6 . Its induction in E. coli causes a novel physiological state called 'quasi-dormancy,' under which cells are fully metabolically active and capable of synthesizing protein even in the total absence of cell growth 5 .
Since MazF induction in E. coli causes degradation of almost all cellular mRNAs, cellular protein synthesis is dramatically inhibited, resulting in complete cell growth arrest. However, an mRNA in which all ACA sequences are altered to other sequences that are no longer cleavable by MazF can be very efficiently translated in cells overproducing MazF. Thus, only the protein from this mRNA is produced at a high yield in the absence of the production of any other cellular protein. Since any ACA sequence in an open reading frame (ORF) can be substituted with non-MazF-cleavable sequences without altering the original amino acid sequence (see Fig. 1 ), any protein may be produced by the single protein production (SPP) system. The SPP system has been previously validated; here, we provide a step-bystep protocol for implementing SPP, on the basis of published methods 5, 7 . Efficiency of protein production. Since, with the SPP system a protein of interest can be exclusively produced in living cells in the absence of other cellular protein production, cells are indeed converted into bioreactors for SPP. The level of protein production may be as high as 20-30% of total cellular proteins 5, 7 . Notably, this level of protein production is not affected by incorporation of toxic amino acid analogs such as selenomethionine and fluorophenylalanine in the medium 7 . In the absence of active cellular protein synthesis, these analogs cannot be incorporated into cellular proteins, thereby minimizing their toxic effect.
Cost-effectiveness. Since the SPP system allows production of a protein of interest in the absence of cell growth, a cell culture can be condensed up to 40 times at the stage of isotope labeling or incorporation of amino acid analogs 7 . Therefore, a 1-l culture can be condensed to a 25-ml culture, which substantially reduces the amount of expensive materials such as amino acid analogs, D 2 O, deuterated 13 C-glucose, and 15 N 13 C double-labeled amino acids. This condensed SPP (cSPP) system consequently reduces the cost of protein production to 2.5% without affecting the protein yield. With the cSPP system, target protein can be produced at a level of up to 1.5 mg ml -1 culture.
Applications of the SPP system
The SPP system is run at low temperature as it uses cold-shock vectors. Therefore, it possesses all the advantages associated with cold-shock protein expression, such as better protein folding, and consequently, better protein solubility. Proteins expressed with other vectors may also be expressed in the SPP system. Notably, some toxic proteins that cannot be expressed in other systems may be expressed in the SPP system because in this sytem, cell growth is not required. The application of the SPP system to membrane proteins is particularly attractive, since isotope-labeling of membrane proteins can be carried out with a very high signal-to-noise ratio. Thus, NMR structural study of membrane proteins may be carried out without purifying them to homogeneity.
Limitations of the SPP system
Unlike other expression systems, the gene of interest has to be engineered to be devoid of ACA sequences. However, this seemingly major hurdle is not a serious problem anymore, due to the recent availability of affordable commercial gene synthesis.
The expression levels of proteins in the SPP system may widely vary due to their stability and toxicity. As a result, the optimum incubation period for the maximum production of a target protein may be different from protein to protein. Therefore, for each protein, conditions for optimum expression have to be determined by a small-scale pilot experiment. When the cSPP system is used, the maximum level of culture condensation without affecting the final protein yield may also be different from protein to protein. Therefore, one should empirically establish the best culture condensation condition for each protein by a small-scale pilot experiment to compare the protein yield of noncondensed culture with those of 10-, 20-, 30-, 40-and 50-fold condensed cultures.
Comparison of the SPP system to other protein production strategies There are two other strategies by which one can produce a protein of interest at a low background protein synthesis 11 as the following description.
Cell-free systems. Recently, cell-free systems using E. coli 12, 13 and wheat germ [14] [15] [16] have become available for large-scale protein production. These cell-free systems also allow SPP as they use mRNA for a specific protein. However, the major drawback of the cell-free systems is that the systems by themselves are quite expensive. In addition, all 20 amino acids and many other factors, including an energy production system (ATP and GTP), have to be added to the reaction. For NMR structural study, all the amino acids have to be isotope-labeled, which substantially increases the cost of protein production.
In contrast, the SPP system uses a defined medium (M9 medium, see REAGENT SETUP) consisting of only NH 4 Cl, glucose and phosphate buffer. The MazF-induced cells in the quasi-dormant state are fully metabolically active in the production of ATP, amino acids and nucleotides and retain their capacity for mRNA and protein synthesis 5 .
Inhibition of E. coli RNA polymerase by rifampicin. With use of T7 vector systems, background cellular protein synthesis can be suppressed by the addition of rifampicin, since this antibiotic specifically inhibits E. coli RNA polymerase 17 . Therefore, SPP may be theoretically achieved with the use of T7 expression system in the presence of rifampicin. However, previous attempts to label a protein of interest with 15 N for in-cell NMR by this method did not improve the quality of HSQC spectra over those obtained from control experiments in the absence of rifampicin 18 .
Critical step in the SPP system: cloning of ACA-less genes The most critical step in the SPP system is the preparation of an ACA-less gene for the protein of interest. If the gene contains only a few ACA sequences, each of these can be altered to a non-MazFcleavable sequence by oligonucleotide-directed site-specific mutagenesis. However, if the gene is large, many ACA sequences are expected (on average, there is one ACA sequence per 64 bases). Therefore, site-directed mutagenesis to remove ACA sequences from this gene would be cumbersome and time consuming.
The problem can be circumvented by chemically synthesizing the entire gene. This is now economically feasible due to the development of new technology, which enables whole gene synthesis at an extremely low cost 19 . This will allow not only the elimination of all ACA sequences, but also importantly, adjustments to the codon usage to ensure optimum expression in E. coli.
Availability of SPP system components
The SPP system is carried out by coexpression of mazF and an ACA-less gene that encodes the target protein. In theory, any expression vector can be used for the SPP system. However, there are some critical points.
The mazF gene should be cloned into a low copy number vector, which regulates its expression very tightly. This will avoid complications arising from very high or untimely exertion of MazF toxicity. As MazF cleaves mRNAs at ACA sequences, the vectors for expressing protein of interest should not contain any ACA sequences in transcribed regions; thus, the 5¢-and 3¢-untranslated regions should be ACA-less in addition to the coding region used for protein fusion. Choice of expression vectors for a target protein is quite empirical as a particular vector may work better for that protein than others 8 . Therefore, it may be recommended to try more than one expression vector in initial trials of the SPP system. In this protocol, we use pCold plasmids. 6 tag after the TEE. pColdI also has the recognition site for Factor Xa for cleaving the (His) 6 tag after purification. With pColdIV, the protein of interest is produced only from the initiation Met residue (Fig. 2 ). E. coli strains Most E. coli strains can be used as a host for the SPP system, including E. coli BL21(DE3), BL21 and W3110 strains, unless they carry chloramphenicol-or ampicillin-resistant markers, since pCold vectors carry the ampicillin marker and pMazF carries the chloramphenicol marker. In our laboratory, BL21 or BL21(DE3) is used for protein expression (Step 6 onward) and DH5a is used for plasmid construction (up to Step 5) . pMazF In this plasmid, the mazF gene is cloned into a low copy number plasmid, pACYC under a lac promoter, so that the mazF gene is inducible with 1 mM IPTG. This plasmid contains the chloramphenicol-resistance gene. M9 medium (per liter) After autoclaving 900 ml water, the following materials are added: 100 ml 10Â M9 salts, 
PROCEDURE
Creation of ACA-less genes TIMING 2-15 d
1| Locate all ACA nucleotide sequences in the ORF of the gene to be expressed. This might be done by importing the sequence into Word and subsequently searching the sequence using the 'find' tool.
2| Use Figure 1 to determine the appropriate base substitutions to replace all ACA nucleotide sequences while retaining the amino acid sequence of the encoded protein. These plasmids are derivatives of cold-shock high expression vectors, pColdI-IV 8 , in which all ACA sequences from the 5¢-and 3¢-untranslated regions are altered to non-MazF-cleavable sequences. They are available from TaKaRa Bio. Inc. For each vector, the sequence shown is followed by the multicloning sites described at the bottom of the figure. With pColdIV(SP-4), an ACA-less gene is cloned at the NdeI site of the multicloning sites so that extra amino acid residues are not added at the N-terminal end of the protein except for the Met residue used for translation initiation. pColdI(SP-4) adds 17 residues, MNHKVHHHHHHIEGRkHM, where an arrow indicates the Factor Xa cleavage site. pColdII(SP-4) adds 12 residues, MNHKVHHHHHHM, and pColdIII(SP-4) adds 7 residues, MNHKVHM, which corresponds to the translation enhancing element in the cspA mRNA 8 . The initiation codons are shown in red. ATG in the multicloning sites is used as the initiation codon only in pColdIV(SP-4). synthetic methods can be used for gene synthesis; in our laboratory, ACA-less genes are synthesized by Codon Devices (http://www.codondevices.com).
Cloning the ACA-less genes into the pCold vector TIMING 2-5 d
4| Clone the ACA-less ORF obtained from Step 3 into one or more of the four pCold(SP-4) vectors (Fig. 2) . Start by setting up individual restriction digests for the ACA-less gene DNA (insert DNA) and the appropriate vector(s) by using suitable restriction enzymes. Incubate as indicated in the manufacturer's instruction. m CRITICAL STEP Any expression vector can be used, however, in this protocol, we have described an example using pCold vectors, which we have successfully used to avoid complications arising due to incompatibility of antibiotics or inducers. Any standard cloning method can be used. Recent technology development allows cloning of any genes into any vectors without restriction enzyme digestion and ligation (http://www.clontech.com/images/pt/PT3941-1.pdf). In this protocol, we describe a cloning method using restriction enzymes and ligase.
5| Purify the restriction-digested insert and the vector DNA by gel electrophoresis followed by gel extraction.
6| Set up the ligation reaction using the purified insert and vector DNA (the ACA-less gene and pCold vectors), as described in the instructions provided with the ligase.
7| Prepare competent cells and transform with the ligation reaction. Plate transformed cells on selective media and incubate overnight at 37 1C. The Inoue method is used in our laboratory 20 to prepare and transform competent cells; however, any method can be used. m CRITICAL STEP Include a positive control (undigested vector DNA) to determine the competency of cells and a negative control (digested, unligated vector DNA or ligated vector DNA without insert) to determine the ligation efficiency.
8| Next day, screen for positive clones by colony polymerase chain reaction (PCR) using vector-specific primers or by other standard methods. Select the positive candidates according to the size of the PCR fragment compared to the undigested vector DNA transformed in Step 7. The PCR fragment from positive colonies is larger than that from the undigested vector DNA by the size of the gene insert. m CRITICAL STEP Remember to restreak colonies used for PCR on fresh plates and grow at 37 1C overnight. These will be needed for subsequent isolation of DNA from positive clones. m CRITICAL STEP DNA from candidate clones should be fully sequenced to confirm that they contain a perfect, unmutated copy of the ACA-less insert.
9| Prepare plasmid DNA for the expression plasmid selected in Step 8 for transformation. Any DNA preparation methods can be used; alkaline lysis with SDS is used in our laboratory 21 . For each transformation, 10 ng DNA is sufficient. ' PAUSE POINT Plasmid DNA can be stored at -20 1C until required.
Preparation of cells for expressing protein TIMING 5-7 d
10| Pick a single colony of an appropriate host E. coli strain from the plate and grow in M9-CAA medium. Use this culture to prepare competent cells for transforming with pMazF, as in Step 7. The Inoue method is used in our laboratory 20 to prepare and transform competent cells, however, any method can be used. ' PAUSE POINT Competent cells can be stored at -80 1C for several months.
11| Transform 50 ml competent cells with 10 ng pMazF and plate on M9-CAA agar plates containing 25 mg ml -1 chloramphenicol. Incubate selective plates overnight at 37 1C. Only cells transformed with pMazF will form colonies on selective plates. m CRITICAL STEP All transformation procedures have to be carried out using M9-CAA plates. LB medium should not be used as it contains contaminating lac inducers, which induce the mazF gene. This will consequently result in mutations in the mazF gene to reduce or eliminate the toxic effect of MazF. Therefore, for liquid cultures, M9-CAA medium should be used.
12|
Next day, pick a single colony from the plate and grow in M9-CAA medium containing 25 mg ml -1 chloramphenicol. Use this culture to prepare pMazF-containing competent cells, as in Step 7. ' PAUSE POINT Competent cells can be stored at -80 1C for several months.
13| Transform 50 ml pMazF-containing competent cells prepared in Step 12 with 10 ng the expression plasmid DNA prepared in
Step 9. Plate transformed cells on M9-CAA agar plates containing 25 mg ml -1 chloramphenicol and 100 mg ml -1 ampicillin to select the cells transformed with expression plasmid. Incubate the plates overnight at 37 1C. Only cells containing both plasmids will form colonies on selective plates. m CRITICAL STEP All transformation procedures have to be carried out using M9-CAA plates. LB medium should not be used as it contains contaminating lac inducers, which may induce the mazF gene. This will consequently result in mutations in the gene of interest to counteract the toxic effect of MazF. Therefore, for liquid cultures, M9 or M9-CAA medium should be used. ? TROUBLESHOOTING (A) Protein production (i) Pick a single colony (containing pMazF and the expression plasmid), using a toothpick, from freshly plated transformed cells in Step 13 and grow overnight in 50 ml M9-CAA medium containing 25 mg ml -1 chloramphenicol and 100 mg ml -1 ampicillin at 37 1C on a shaker (at approximately 150 r.p.m.). (ii) Add the overnight culture to 1 l M9-CAA medium containing 25 mg ml -1 chloramphenicol and 100 mg ml -1 ampicillin in a 4-l culture flask and incubate at 37 1C on a shaker until mid-log phase. (iii) Monitor the optical density of the culture at 600 nm every 60 min. Make sure that the culture is growing exponentially.
The OD 600 of the culture should increase linearly in a graph of log OD 600 versus time. (ix) Resuspend the cell pellet in 25-ml M9 medium containing Lys (100 mg ml -1 ), Phe (100 mg ml -1 ), Thr (100 mg ml -1 ), Ile (50 mg ml -1 ), Leu (50 mg ml -1 ), Val (50 mg ml -1 ), 25 mg ml -1 chloramphenicol and 100 mg ml -1 ampicillin (this will condense the cell culture 40-fold). m CRITICAL STEP Other amino acid analogs (such as fluorophenylalanine) may be directly added at this step, if there is no appropriate way to block the biosynthesis of the target amino acid. A strain that is an auxotroph for a specific amino acid (for example, a phe -strain) may be used. In this case, cells should be washed with M9 medium after Step 14B(viii) to remove the amino acid added in the medium and recentrifuged before proceeding. (x) Transfer the culture into a 250-ml culture flask and incubate at 15 1C with shaking for 30 min to inhibit endogenous Met biosynthesis 22 . 
ANTICIPATED RESULTS
Examination of the signal-to-noise ratio The best method to examine the signal-to-noise ratio for isotope-labeling experiments in the SPP system is to compare 35 S-Met incorporation into the protein to be expressed with that into background cellular proteins. Figure 3 shows 35 S-Met incorporation into human eotaxin, a 74-residue chemokine, using the SPP system with (right panel) and without (left panel) induced MazF. It clearly demonstrates that the background cellular protein synthesis almost completely disappears 3 h after MazF induction. In this experiment, the ACA-less eotaxin gene was chemically synthesized with the E. coli optimum codon usage and cloned into pColdI(SP-2), a prototype of pColdI(SP-4) that contains one ACA sequence in the 3¢-untranslated region.
As can be seen in Figure 3 , upon MazF induction, a very high signal-to-noise ratio is obtained for eotaxin, which is maintained at least for 96 h. This exclusive production of a protein from an ACA-less gene has been observed for many other proteins from human, yeast to bacteria 5 . It has also been shown that the addition of ACA-sequences to these ACA-less genes dramatically reduces the 35 S-Met incorporation into the respective proteins 5 .
High yield of protein production As expected from the efficient 35 S-Met incorporation into a protein of interest in the SPP system (Fig. 3) , the amount of protein produced in the SPP system may reach as high as 20-30% of total cellular proteins 5 . Figure 4 shows Coomassie blue staining of a gel analyzing total cellular protein expression during a 96-h incubation of cells using the SPP system. An ACA-less cspA gene is expressed from pColdIV(SP-2) in this system (right panel). This gene encodes the major cold-shock protein and contains three ACA sequences in the wild type. Therefore, the wild-type cspA gene is hardly expressed (left panel). On the other hand, the ACA-less cspA gene is consistently expressed and CspA protein (indicated by an arrow) accumulates over the 96-h incubation period. The final yield was estimated at approximately 25% of total cellular proteins. Note that, in these experiments, the same amount of culture was used for the SDS-PAGE analysis. Therefore, the fact that the density of all the cellular protein bands was almost unchanged during the 96-h incubation (for both right and left panels) clearly confirms the effectiveness of the SPP system, which completely blocks cellular protein synthesis.
The cSPP system achieves not only a high yield of protein production, but also effective reduction in the cost of chemicals used for isotope labeling of proteins. Figure 5 shows the effect of culture condensation (X1-X100) on the protein yield. Cell lysate from 300 ml of the noncondensed culture was applied to SDS-PAGE in the first lane. The equivalent amount of cells from the condensed cultures was applied to each well for examination of protein yields for condensed cultures. For EnvZB production, condensing the culture up to 40 times does not affect the protein yield, giving a 97.5% reduction in the cost of protein production. Approximately, 1.5 mg EnvZB protein was obtained from 1 ml of the 40-times-condensed culture. 
